Lifevantage PE Ratio 2010-2025 | LFVN
Current and historical p/e ratio for Lifevantage (LFVN) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Lifevantage PE ratio as of July 25, 2025 is 17.81.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Lifevantage PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2025-07-25 |
13.71 |
|
19.87 |
| 2025-03-31 |
14.53 |
$0.69 |
21.06 |
| 2024-12-31 |
17.43 |
$0.56 |
31.12 |
| 2024-09-30 |
11.98 |
$0.32 |
37.43 |
| 2024-06-30 |
6.34 |
$0.23 |
27.56 |
| 2024-03-31 |
5.94 |
$0.28 |
21.22 |
| 2023-12-31 |
5.86 |
$0.23 |
25.49 |
| 2023-09-30 |
6.27 |
$0.20 |
31.34 |
| 2023-06-30 |
3.98 |
$0.20 |
19.91 |
| 2023-03-31 |
3.26 |
$-0.06 |
0.00 |
| 2022-12-31 |
3.35 |
$-0.05 |
0.00 |
| 2022-09-30 |
3.35 |
$0.04 |
83.83 |
| 2022-06-30 |
3.86 |
$0.24 |
16.09 |
| 2022-03-31 |
4.19 |
$0.70 |
5.99 |
| 2021-12-31 |
5.57 |
$0.73 |
7.63 |
| 2021-09-30 |
5.96 |
$0.98 |
6.09 |
| 2021-06-30 |
6.47 |
$0.90 |
7.19 |
| 2021-03-31 |
8.24 |
$0.81 |
10.17 |
| 2020-12-31 |
8.21 |
$0.80 |
10.26 |
| 2020-09-30 |
10.63 |
$0.84 |
12.66 |
| 2020-06-30 |
11.91 |
$0.79 |
15.08 |
| 2020-03-31 |
9.07 |
$0.79 |
11.49 |
| 2019-12-31 |
13.75 |
$0.80 |
17.19 |
| 2019-09-30 |
12.07 |
$0.56 |
21.55 |
| 2019-06-30 |
11.43 |
$0.50 |
22.87 |
| 2019-03-31 |
12.59 |
$0.45 |
27.97 |
| 2018-12-31 |
11.62 |
$0.45 |
25.82 |
| 2018-09-30 |
9.68 |
$0.41 |
23.61 |
| 2018-06-30 |
5.61 |
$0.41 |
13.69 |
| 2018-03-31 |
3.18 |
$0.21 |
15.14 |
| 2017-12-31 |
4.19 |
$0.09 |
46.59 |
| 2017-09-30 |
3.72 |
$0.09 |
41.30 |
| 2017-06-30 |
3.81 |
$0.11 |
34.68 |
| 2017-03-31 |
4.73 |
$0.26 |
18.19 |
| 2016-12-31 |
7.18 |
$0.33 |
21.76 |
| 2016-09-30 |
8.33 |
$0.42 |
19.84 |
| 2016-06-30 |
11.98 |
$0.42 |
28.52 |
| 2016-03-31 |
8.02 |
$0.26 |
30.83 |
| 2015-12-31 |
8.39 |
$0.26 |
32.25 |
| 2015-09-30 |
4.99 |
$0.22 |
22.70 |
| 2015-06-30 |
3.27 |
$0.49 |
6.67 |
| 2015-03-31 |
4.87 |
$0.63 |
7.73 |
| 2014-12-31 |
8.02 |
$0.70 |
11.45 |
| 2014-09-30 |
7.03 |
$0.84 |
8.37 |
| 2014-06-30 |
8.88 |
$0.70 |
12.69 |
| 2014-03-31 |
8.08 |
$0.56 |
14.43 |
| 2013-12-31 |
10.17 |
$0.63 |
16.16 |
| 2013-09-30 |
14.68 |
$0.42 |
34.96 |
| 2013-06-30 |
14.31 |
$0.42 |
34.08 |
| 2013-03-31 |
14.49 |
$0.70 |
20.71 |
| 2012-12-31 |
13.50 |
$0.14 |
96.46 |
| 2012-09-30 |
21.15 |
$0.49 |
43.17 |
| 2012-06-30 |
17.45 |
$0.42 |
41.55 |
| 2012-03-31 |
23.19 |
$-3.78 |
0.00 |
| 2011-12-31 |
8.82 |
$-4.34 |
0.00 |
| 2011-09-30 |
9.25 |
$-4.27 |
0.00 |
| 2011-06-30 |
9.25 |
$-4.34 |
0.00 |
| 2011-03-31 |
4.38 |
$-0.98 |
0.00 |
| 2010-12-31 |
2.40 |
$-1.05 |
0.00 |
| 2010-09-30 |
3.08 |
$-1.54 |
0.00 |
| 2010-06-30 |
3.14 |
$-1.47 |
0.00 |
| 2010-03-31 |
2.40 |
$-1.68 |
0.00 |
| 2009-12-31 |
1.54 |
$-1.54 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.173B |
$0.200B |
|
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
|
